Mckesson
McKesson Corporation, a leading name in the pharmaceutical preparation manufacturing industry, is headquartered in the United States. Founded in 1833, McKesson has established itself as a pivotal player in healthcare, providing a wide range of services including pharmaceutical distribution, healthcare management, and technology solutions.
With major operations across North America, McKesson is renowned for its commitment to improving patient care through innovative products and services. The company’s core offerings include prescription medications, medical supplies, and health information technology, all designed to enhance efficiency and accessibility in healthcare delivery.
Recognised for its market leadership, McKesson consistently ranks among the top companies in the Fortune 500, reflecting its significant impact on the healthcare landscape. Its dedication to quality and service excellence sets McKesson apart in a competitive industry.
+22 vs industry average
Mckesson’s score of 60 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Mckesson?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2028
Reported emissions
Scope 3 accounts for ••• of total emissions.
Mckesson's reported carbon emissions
McKesson Corporation, a US-based pharmaceutical preparation manufacturer, reported a total of approximately 3.61 trillion kg CO2e in Scope 3 emissions for fiscal year 2025. This figure is a substantial portion of their overall emissions, with Scope 1 emissions standing at about 72.2 million kg CO2e and Scope 2 (market-based) emissions at approximately 120 million kg CO2e for the same year. In fiscal year 2024, McKesson's total emissions were approximately 3.26 trillion kg CO2e, with Scope 3 emissions at about 32.57 billion kg CO2e, Scope 1 at roughly 79.8 million kg CO2e, and Scope 2 (market-based) at approximately 152.1 million kg CO2e. McKesson has established Science Based Targets initiative (SBTi) commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 50.4% by fiscal year 2032 from a fiscal year 2020 base year. Furthermore, they aim for 70% of their suppliers, by spend for purchased goods and services, to have science-based targets by fiscal year 2027. These targets are aligned with limiting global warming to 1.5°C.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Mckesson’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Mckesson yet.
Scope 3 top emissions categories
7 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives
Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Mckesson
Frequently asked questions
Common questions about Mckesson’s sustainability data and climate commitments
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project